Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amoxicillin trihydrate 588.235mg equivalent to amoxycillin 500 mg; amoxicillin trihydrate 584.8mg equivalent to amoxycillin 500 mg - capsule - 500 mg - active: amoxicillin trihydrate 588.235mg equivalent to amoxycillin 500 mg excipient: gelatin iron oxide red iron oxide yellow magnesium stearate titanium dioxide active: amoxicillin trihydrate 584.8mg equivalent to amoxycillin 500 mg excipient: erythrosine gelatin indigo carmine iron oxide yellow magnesium stearate titanium dioxide - for the treatment of infections due to susceptible organisms.

Τανζανία - Αγγλικά - Tanzania Medicinces & Medical Devices Authority

glaxosmithkline pharmaceutical kenya limited, kenya - amoxicillin - capsules - 500

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - amoxicillin trihydrate - oral capsule - 500mg

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxycillin trihydrate; amoxycillin -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin sodium, quantity: 1.06 g (equivalent: amoxicillin, qty 1 g) - injection, powder for - excipient ingredients: - amoxil parenteral is intended for use where the patient's condition precludes the administration of the oral form. it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriological studies, including sensitivity tests, and clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. septicaemia: (bacterial) h. influenzae; e. coli (see microbiology); p.mirabilis; streptococcus; s. pneumoniae; s. faecalis and salmonella typhi. skin and skin structure: staphylococcus, non-penicillinase-producing; streptococcus; e. coli (see microbiology). respiratory, acute and chronic: haemophilus influenzae; streptococcus; s. pneumoniae; staphylococcus, non-penicillinase producing; e. co

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amoxicillin trihydrate 113.955 mg/ml equivalent to amoxycillin 100 mg/ml ((6% overage also added - amount used based on potency));  ;  ; amoxicillin trihydrate 116.96 mg/ml equivalent to amoxcillin 100 mg/ml - powder for oral suspension - 100 mg/ml - active: amoxicillin trihydrate 113.955 mg/ml equivalent to amoxycillin 100 mg/ml ((6% overage also added - amount used based on potency))     excipient: carmellose sodium lemon flavour 15.81.4309 peach flavour 15.81.4447 sodium benzoate strawberry flavour 15.81.4607 sucrose active: amoxicillin trihydrate 116.96 mg/ml equivalent to amoxcillin 100 mg/ml excipient: aspartame carmellose sodium crospovidone silica hydrophobic colloidal lemon-peach-strawberry flavour magnesium stearate sodium benzoate xanthan gum - amoxil is indicated for the treatment of infections due to susceptible organisms.

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - amoxicillin trihydrate - oral capsule - 500mg

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin trihydrate -

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - amoxicillin trihydrate - oral capsule - 500mg

Τανζανία - Αγγλικά - Tanzania Medicinces & Medical Devices Authority

b&o pharm, france - amoxicillin - capsules - 250